The migration of multilineage "passenger leukocytes" from transplanted organs and their ubiquitous survival in successfully treated human recipients for as long as 30 years (microchimerism) has been postulated to be an essential condition for organ allograft acceptance and the explanation for a number of previously enigmatic posttransplant events (1, 2). Following organ revascularization in either humans or rodents, donor leukocytes appear in large numbers in the recipient blood but usually diminish over a few days to a level undetectable with flow cytometry (2-5). We have construed the persistence of donor cells thereafter as prima facie evidence of the presence of hematopoietic stem and precursor cells (1,2, 6).
The migration of multilineage "passenger leukocytes" from transplanted organs and their ubiquitous survival in successfully treated human recipients for as long as 30 years (microchimerism) has been postulated to be an essential condition for organ allograft acceptance and the explanation for a number of previously enigmatic posttransplant events (1, 2) . Following organ revascularization in either humans or rodents, donor leukocytes appear in large numbers in the recipient blood but usually diminish over a few days to a level undetectable with flow cytometry (2) (3) (4) (5) . We have construed the persistence of donor cells thereafter as prima facie evidence of the presence of hematopoietic stem and precursor cells (1, 2, 6) .
When the blood compartment is serially sampled in longsurviving human organ recipients, the levels of donor cells fluctuate (7) , presumably reflecting cyclic activity of these stem cells. Taniguchi et al. (8) showed that primitive CD45 + cells purified from adult mouse livers unfailingly reconstituted all hematolymphopoietic lineages in supralethally irradiated adult mouse recipients. We present here direct evidence that supralethally irradiated adult rats can be consistently rescued by syngeneic liver transplantation, and that heart transplantation has a less dramatic but significant therapeutic effect.
Inbred Lewis (RT1!, LEW) rats weighing 200-250 g (8-10 weeks old) were purchased from Harlan Sprague Dawley (Indianapolis, IN) and kept in a laminar-flow specific-pathogen-free environment. Orthotopic liver and heterotopic (abdominal) heart transplantation were performed as described previously (5) . After death of the donor by exsanguination, the grafts were flushed intravascularly with chilled lactated Ringer's solution until the venous effiuent was clear.
Bone marrow cells were harvested from the tibias and femurs, and processed in RPM I 1640 supplemented with 25 mM Hepes buffer, 2 mM L-glutamine, 50 D/ml penicillin, and 50 J..lg/ml streptomycin (all from Gibco, Grand Island, NY) (5).
Trypan blue exclusion testing uniformly showed >95% cell viability_ The cell suspensions were administered into the recipient penile vein.
A reagent panel containing monoclonal antibodies against all of the principal leukocyte subsets was used to determine lineages of the control and reconstituted animals (panel available on request), Most experiments were performed with male donors and recipients. However, in 2 liver recipients, male ~ female transplantation was performed and the tissues and organs of the hematopoietically reconstituted recipient were studied with polymerase chain reaction and Southern hybridization, usiiig rat V-chromosome (sex determining region Y [SRY]) specific primers (9) . This provided proof of hematopoietic sex change in the reconstituted animals as opposed to recovery of the cytoablated recipient stem cells.
Recipients were irradiated with 9.5 Gy, delivered from a cesium source. All cell or organ transplantations were done 4-8 hr after completion of irradiation. Survival was determined of animals receiving 4 different doses of syngeneic bone marrow, and of those given liver and heart grafts ( Table  1 ). In addition, 6 irradiated animals of similar size were given 3 ml of fresh whole blood, which was an estimated 251Jt of their total blood volume. This amount of transfusion exceeded by an estimated thousand-fold or more any residual blood in the thoroughly flushed organs used for transplantation.
All untreated animals died within 12 days. Heart transplantation significantly prolonged survival (P<0.05). One of 6 cardiac recipients was permanently rescued and 4 of the 5 others lived 2-6 days beyond the longest surviving nontreated control. These results were at least as good as those obtained with a suboptimal dose of 0.5x 10 6 bone marrow cells (P=0.109 vs. control) and with the infusion of 3 ml of whole blood (P=0.007 vs. controll. Liver transplantation resulted in permanent survival of 5 of 6 irradiated recipients with full multilineage reconstitution. a rescue effect that was not significantly different from that following infusion of 1,5, or lOX 10 6 bone marrow cells (Table 1) .
Because frequent blood sampling and other manipulations The rate and the extent of circulating leukocyte ( Fig. 1 ) and hematocrit restoration (Fig. 2) were similar after liver transplantation and infusions of 1 X 10 6 bone marrow cells, Rats given a lO-fold higher dose of bone marrow cells (lX10 7 ) recovered more quickly ( Figs. 1 and 2 ), The sequence of lineage recovery was similar in the liver and bone marrow recipients, and appeared to be dependent on the number of progenitor cells, The FACS profile of animals after various kinds of hematopoietic reconstitution is shown in Figure 4 . The reconstituted cells in cross-sex liver transplantations (male ---+ female) were predominantly donor (Fig. 5) and were, of course, least densely represented in the heart, The initial delay in postoperative weight gain of liver compared with bone marrow recipients (Fig, 3) was explained by the greater stress and metabolic depletion associated with the hepatic replacement compared with the less traumatic penile vein infusion of bone marrow cells. After 3 weeks, the liver recipients had catch-up weight gain, and they achieved parity with all other reconstituted groups by day 50 (Fig. 3) .
These experiments suggest that the difference between the chimerism (and tolerance) following classical bone marrow transplantation and that produced by the donor ("passenger") leukocytes of whole organs is purely semantic. While describing the multilineage character of the microchimerism in human and animal organ recipients (1, 2, 6, 10. 11), we have emphasized the invariable histopathologic prominence of dendritic cells because their presence was so much in conflict with the literature preceding 1992. The previous literature had associated these cells almost exclusively with rejection rather than graft acceptance. We have recently summarized elsewhere the impressive evidence acquired since then of a key tolerogenic role played by the dendritic cells, particularly when iIi their precursor stages (J2). However, preoccupation with a single leukocyte lineage could obscure an understanding of the complex cell interactions that we are seeking to understand and manipulate. We be- lieve it unlikely that transplantation tolerance can be fully explained, reliably induced, or efficiently sustained by any single lineage (5, 6, 13) .
In the experiments reported herein, heart transplantation also had a significant effect on postirradiation survival, less dramatic than the liver but similar to that of a suboptimal dose of donor bone marrow or a large blood transfusion. The pennanent hematopoietic reconstitution of one of the heart recipients and prolongation of survival of 4 of 5 others strengthen our earlier contention that tolerogenicity is an inherent capability common to all organized tissues and organs, with variations in outcome dictated by the quantity and lineage profile of bone marrow-derived leukocytes contained in the graft (), 2, 5, 6, 13) .
No record could be found in the literature suggesting that these simple and direct reconstitution experiments had been performed previously, presumably because of the assumption that organ transplantation involves a unidirectional hostversus-graft immune reaction (the one-way paradigm). Leszczynski et a1. (}4) showed that lXl0 6 recipient inflammatory cells extracted from rejecting rat kidney allografts contained enough host stem cells to fully reconstitute supralethally irradiated animals of the recipient strain. The experiments reported herein showed that the transplanted organ (especially the liver) brings enough donor stem cells to provide the basis of the sustained bidirectional immune reaction that we have postulated to be the basis of allograft acceptance and the usual form of transplantation tolerance (the two-way paradigm [5, 15] ).
Studies in vivo have documented the importance of CD40-gp39 interactions in the development of T-dependent antibody responses to foreign and auto-antigens. In this report, we demonstrate that allograft rejection is also associated with strong induction of CD40 and gp39 transcripts. When treatment was initiated at the time of transplant, MRl, a mAb specific for gp39, induced markedly prolonged survival of fully disparate murine cardiac allografts in both naive and sensitized hosts. However, when therapy was delayed until postoperative day 5, anti-gp39 failed to prolong graft survival. Allografts from recipients treated with MRl from the time of transplantation showed decreased expression of transcripts for the macrophage effector molecule, inducible nitric oxide synthase, but essentially unaltered expression of B7 molecules and T cell cytokine transcripts (interleukin [ILJ-2, interferon-y, IL-IO, and IL-4) relative to control allografts. In addition, alloantibody responses in the MRl-treated mice were profoundly inhibited. However, our studies using B cell-deficient mice indicated that the ability of MRl to prolong allograft survival was not dependent on B cells. These data suggest that blockade of CD40-gp39 interactions may inhibit allograft rejection primarily by interfering with T cell help for effector functions, rather than by interference with T cell activation.
Activated T cells play a pivotal role in the rejection of allografts (1, 2) , Activation ofT cells to proliferate and secrete cytokines requires both recognition of major histocompatibil-
